IDEXX Laboratories, Inc. IDXX
519.26
5.87
1.14%
as of 25 Sep
- Market cap
- $40.2B
- P/E
- 36.2×
Follow IDXX
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
IDEXX Laboratories, Inc. (IDXX) Operating cash flow
IDEXX Laboratories, Inc.'s operating cash flow for fiscal 2025 was $1.2B, up 27.2% from $929.0M in fiscal 2024. Over the twelve months to 30 June 2026 it was $1.4B. Over the past ten years it has ranged from $221.8M (fiscal 2015) to $1.2B (fiscal 2025) — the current reading is the highest in ten years. Operating cash flow has risen for 3 consecutive fiscal years. IDEXX Laboratories, Inc. ranks 7th of 52 Diagnostics & Research companies by operating cash flow.
Operating cash flow, annual
Annual
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $1.2B | 27.21% |
| FY2024 | $929.0M | 2.48% |
| FY2023 | $906.5M | 66.95% |
| FY2022 | $543.0M | (28.13%) |
| FY2021 | $755.5M | 16.59% |
| FY2020 | $648.1M | 41.14% |
| FY2019 | $459.2M | 14.77% |
| FY2018 | $400.1M | 7.18% |
| FY2017 | $373.3M | 10.13% |
| FY2016 | $338.9M | 52.81% |
Quarterly
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | $347.2M | 30.39% |
| Mar 2026 | $266.2M | (25.16%) |
| Dec 2025 | $355.8M | (11.58%) |
| Sep 2025 | $402.3M | 116.61% |
| 42 more quarters | Free account |
Against its own ten years
Low $221.8M
High $1.2B
Ten-year median
$543.0M
Current reading's percentile
100
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| IQV IQVIA Holdings Inc. compare | $2.8B |
| DGX Quest Diagnostics Incorporated compare | $1.9B |
| A Agilent Technologies, Inc. compare | $1.6B |
| IDXX IDEXX Laboratories, Inc. | $1.4B |
| ILMN Illumina, Inc. compare | $1.1B |
| MTD Mettler-Toledo International, Inc. compare | $975.2M |
| WAT Waters Corporation compare | $549.6M |
| NTRA Natera, Inc. compare | $228.2M |
| GH Guardant Health, Inc. compare | −$185.2M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on IDXX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement